Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

Rocket’s adeno-associated viral (AAV) vector-based cardiovascular portfolio includes a late-stage program for Danon Disease, a devastating heart failure condition resulting in thickening of the ...

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price target lifted by stock analysts at Scotiabank from $51.00 to $52.00 in a note issued to investors on Monday,Benzinga reports. The ...

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat ...

Rocket Lab USA, Inc. (NASDAQ:RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1... Rocket Lab USA, Inc. (RKLB) reported Q1 EPS of ($0.06), $0.02 worse ...

Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security, and global markets, today announced the award of the Short/Medium Range Sub-Orbital ...

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

On Wednesday, Stifel analysts reiterated their Buy rating and $27.00 price target for Rocket Lab USA (NASDAQ:RKLB) shares, which ...

The "Space Launch Services Market Report 2025" has been added to ResearchAndMarkets.com's offering.The space launch services market size has grown rapidly in recent years. It will grow from $10.34 ...

W hen Musk and his allies turned their attention to the FAA last month, they identified a problem: The communications ...

Throughout the immersive experience in the hospital, a mediator accompanies the young patient, answers their questions, adapts to their interests and desires. ?She is present at every moment. It can ...